FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jeanne Lusher

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Procedures

Physiology

Immune Tolerance

Co-author Network

Publications

TOP 3
Veronica H Flood; Kenneth D Friedman; Joan Cox Gill; Sandra L Haberichter; Raymond G Hoffmann; W Keith Hoots; Cindy A Leissinger; Jeanne M Lusher; Thomas C Abshire; Brian R Branchford; Deborah L Brown; Pamela A Christopherson; Jorge Di Paola; Amy L Dunn; Margaret V Ragni; Amy D Shapiro; Robert R Montgomery
No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation.
Jeanne M Lusher
Development and introduction of recombinant factor VIII--a clinician's experience.
Daniel B Bellissimo; Pamela A Christopherson; Veronica H Flood; Kenneth D Friedman; Joan Cox Gill; Sandra L Haberichter; W Keith Hoots; Cindy Leissinger; Jeanne M Lusher; Margaret V Ragni; Amy D Shapiro; Thomas C Abshire; Robert R Montgomery
VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jeanne Lusher (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Veronica H Flood; Kenneth D Friedman; Joan Cox Gill; Sandra L Haberichter; Raymond G Hoffmann; W Keith Hoots; Cindy A Leissinger; Jeanne M Lusher; Thomas C Abshire; Brian R Branchford; Deborah L Brown; Pamela A Christopherson; Jorge Di Paola; Amy L Dunn; Margaret V Ragni; Amy D Shapiro; Robert R Montgomery
No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation.
Blood 2013;121(18):3742-4.
2012: Jeanne M Lusher
Development and introduction of recombinant factor VIII--a clinician's experience.
Haemophilia : the official journal of the World Federation of Hemophilia 2012;18(4):483-6.
2012: Daniel B Bellissimo; Pamela A Christopherson; Veronica H Flood; Kenneth D Friedman; Joan Cox Gill; Sandra L Haberichter; W Keith Hoots; Cindy Leissinger; Jeanne M Lusher; Margaret V Ragni; Amy D Shapiro; Thomas C Abshire; Robert R Montgomery
VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population.
Blood 2012;119(9):2135-40.
2012: B Sørensen; Y Dargaud; G Kenet; Jeanne M Lusher; Andrew D Mumford; Steven W Pipe; A Tiede
On-demand treatment of bleeds in haemophilia patients with inhibitors: strategies for securing and maintaining predictable efficacy with recombinant activated factor VII.
Haemophilia : the official journal of the World Federation of Hemophilia 2012;18(2):255-62.
2011: Diane J Aschman; Ann D Forsberg; Jeanne M Lusher; Amy D Shapiro; Thomas C Abshire; Roshni Kulkarni
A community-based partnership to promote information infrastructure for bleeding disorders.
American journal of preventive medicine 2011;41(6 Suppl 4):S332-7.
2011: Akash Nahar; Meera Chitlur; Jeanne M Lusher; Yaddanapudi Ravindranath; Cynthia Sabo; Madhvi Rajpurkar
Plasma homocysteine levels, methylene tetrahydrofolate reductase polymorphisms, and the risk of thromboembolism in children.
Journal of pediatric hematology/oncology 2011;33(5):330-3.
2011: M Chitlur; M Escobar; J Ingerslev; G Kenet; D Nugent; M Othman; G E Rivard; B Sorensen; G Young; Jeanne M Lusher
Standardization of thromboelastography: a report from the TEG-ROTEM working group.
Haemophilia : the official journal of the World Federation of Hemophilia 2011;17(3):532-7.
2011: M U Callaghan; Madhvi Rajpurkar; M Chitlur; I Warrier; Jeanne M Lusher
Immune tolerance induction in 31 children with haemophilia A: is ITI less successful in African Americans?
Haemophilia : the official journal of the World Federation of Hemophilia 2011;17(3):483-9.
2010: Meera Chitlur; Jeanne M Lusher
Standardization of thromboelastography: values and challenges.
Seminars in thrombosis and hemostasis 2010;36(7):707-11.
2010: Veronica H Flood; Joan Cox Gill; Patricia A Morateck; Pamela A Christopherson; Kenneth D Friedman; Sandra L Haberichter; Brian R Branchford; Raymond G Hoffmann; Thomas C Abshire; Jorge A Di Paola; W Keith Hoots; Cindy Leissinger; Jeanne M Lusher; Margaret V Ragni; Amy D Shapiro; Robert R Montgomery
Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor.
Blood 2010;116(2):280-6.
2010: Alphan Kupesiz; Madhvi Rajpurkar; Indira Warrier; Wendy Hollon; Ozgur Tosun; Jeanne M Lusher; Meera Chitlur
Tissue plasminogen activator induced fibrinolysis: standardization of method using thromboelastography.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2010;21(4):320-4.
2010: O Alphan Kupesiz; Meera Chitlur; Wendy Hollon; Ozgun Tosun; Ron L Thomas; Indira Warrier; Jeanne M Lusher; Madhvi Rajpurkar
Fibrinolytic parameters in children with noncatheter thrombosis: a pilot study.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2010;21(4):313-9.
2010: Jeanne M Lusher; Steven W Pipe; S Alexander; D Nugent
Prophylactic therapy with Fibrogammin P is associated with a decreased incidence of bleeding episodes: a retrospective study.
Haemophilia : the official journal of the World Federation of Hemophilia 2010;16(2):316-21.
2009: Jeanne M Lusher; Inge Scharrer
Evolution of recombinant factor VIII safety: KOGENATE and Kogenate FS/Bayer.
International journal of hematology 2009;90(4):446-54.
2009: Madhvi Rajpurkar; K Boldt-Macdonald; R McLenon; M U Callaghan; Meera Chitlur; Jeanne M Lusher; C Becker
Ethanol lock therapy for the treatment of catheter-related infections in haemophilia patients.
Haemophilia : the official journal of the World Federation of Hemophilia 2009;15(6):1267-71.
2009: Roshni Kulkarni; J Michael Soucie; Jeanne M Lusher; R Presley; Amy D Shapiro; J Gill; Marilyn J Manco-Johnson; M Koerper; Prasad Mathew; Thomas C Abshire; D Dimichele; Keith Hoots; R Janco; D Nugent; S Geraghty; Bruce Evatt
Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention's (CDC) Universal Data Collection (UDC) project.
Haemophilia : the official journal of the World Federation of Hemophilia 2009;15(6):1281-90.
2009: Meera Chitlur; Indira Warrier; Madhvi Rajpurkar; Jeanne M Lusher
Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006).
Haemophilia : the official journal of the World Federation of Hemophilia 2009;15(5):1027-31.
2009: Michael Recht; L Nemes; M Matysiak; M Manco-Johnson; Jeanne M Lusher; M Smith; P Mannucci; C Hay; T Abshire; A O'Brien; B Hayward; C Udata; D A Roth; S Arkin
Clinical evaluation of moroctocog alfa (AF-CC), a new generation of B-domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: demonstration of safety, efficacy, and pharmacokinetic equivalence to full-length recombinant factor VIII.
Haemophilia : the official journal of the World Federation of Hemophilia 2009;15(4):869-80.
2008: Zhihong J Wang; Nkechi Onwuzurike; Michael U Callaghan; Madhvi Rajpurkar; Meera Chitlur; Jeanne M Lusher
Decreased clearance of von Willebrand factor in a patient with type 2B von Willebrand disease following development of immune thrombocytopenia.
Pediatric blood & cancer 2008;51(3):416-8.
2008: Meera Chitlur; Indira Warrier; Madhvi Rajpurkar; Wendy Hollon; Lolita Llanto; Carol Wiseman; Jeanne M Lusher
Thromboelastography in children with coagulation factor deficiencies.
British journal of haematology 2008;142(2):250-6.
2007: Darintr Sosothikul; Panya Seksarn; Sureeporn Pongsewalak; Usa Thisyakorn; Jeanne M Lusher
Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection.
Thrombosis and haemostasis 2007;97(4):627-34.
2007: Bülent Ozgönenel; Madhvi Rajpurkar; Jeanne M Lusher
How do you treat bleeding disorders with desmopressin?
Postgraduate medical journal 2007;83(977):159-63.
2007: Louis M Aledort; B L Evatt; Jeanne M Lusher; A P Brownstein
HIV and hemophilia.
Journal of thrombosis and haemostasis : JTH 2007;5(3):607-10.
2007: Darintr Sosothikul; Panya Seksarn; Jeanne M Lusher
Pediatric reference values for molecular markers in hemostasis.
Journal of pediatric hematology/oncology 2007;29(1):19-22.
2007: Madhvi Rajpurkar; Indira Warrier; Meera Chitlur; Cynthia Sabo; Mary Jane Frey; Wendy Hollon; Jeanne M Lusher
Pulmonary embolism-experience at a single children's hospital.
Thrombosis research 2007;119(6):699-703.
2006: Giancarlo Castaman; Francesco Rodeghiero; Alberto Tosetto; A Cappelletti; Francesco Baudo; J C J Eikenboom; Augusto B Federici; Stefan Lethagen; S Linari; Jeanne M Lusher; M Nishino; P Petrini; A Srivastava; J S Ungerstedt
Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study.
Journal of thrombosis and haemostasis : JTH 2006;4(10):2164-9.
2006: Roshni Kulkarni; K P Ponder; Andra H James; J Michael Soucie; Marion A Koerper; W Keith Hoots; Jeanne M Lusher
Unresolved issues in diagnosis and management of inherited bleeding disorders in the perinatal period: a White Paper of the Perinatal Task Force of the Medical and Scientific Advisory Council of the National Hemophilia Foundation, USA.
Haemophilia : the official journal of the World Federation of Hemophilia 2006;12(3):205-11.
2006: Jeanne M Lusher
Milestones in hemophilia and concepts in future clinical trial design.
Seminars in hematology 2006;43(1 Suppl 1):S84-7.
2005: Jeanne M Lusher; D A Roth
The safety and efficacy of B-domain deleted recombinant factor VIII concentrates in patients with severe haemophilia A: an update.
Haemophilia : the official journal of the World Federation of Hemophilia 2005;11(3):292-3.
2005: Craig M Kessler; Joan Cox Gill; Gilbert C White; Amy D Shapiro; S Arkin; D A Roth; X Meng; Jeanne M Lusher
B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-way crossover study.
Haemophilia : the official journal of the World Federation of Hemophilia 2005;11(2):84-91.
2005: Wolfhart Kreuz; Joan Cox Gill; Chantal Rothschild; Marilyn J Manco-Johnson; Jeanne M Lusher; Elke Kellermann; Eduard Gorina; Peter J Larson
Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A: results of an international clinical investigation.
Thrombosis and haemostasis 2005;93(3):457-67.
2005: Amy D Shapiro; Jorge Di Paola; Alice Cohen; K John Pasi; Margaret A Heisel; Victor S Blanchette; Thomas C Abshire; W Keith Hoots; Jeanne M Lusher; Claude Negrier; Chantal Rothschild; David A Roth
The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B.
Blood 2005;105(2):518-25.
2004: Jeanne M Lusher
Is the incidence and prevalence of inhibitors greater with recombinant products? No.
Journal of thrombosis and haemostasis : JTH 2004;2(6):863-5.
2004: Jeanne M Lusher; CF Abildgaard; S Arkin; P M Mannucci; R Zimmermann; L Schwartz; Deborah Hurst
Human recombinant DNA-derived antihemophilic factor in the treatment of previously untreated patients with hemophilia A: final report on a hallmark clinical investigation.
Journal of thrombosis and haemostasis : JTH 2004;2(4):574-83.
2004: W K Hoots; Jeanne M Lusher
High-titer inhibitor development in hemophilia A: lack of product specificity.
Journal of thrombosis and haemostasis : JTH 2004;2(2):358-9.
2003: Jerry S Powell; Margaret V Ragni; Gilbert C White; Jeanne M Lusher; Carol Hillman-Wiseman; Tom E Moon; Veronica Cole; Sandhya Ramanathan-Girish; Holger Roehl; Nancy Sajjadi; Douglas J Jolly; Deborah Hurst
Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion.
Blood 2003;102(6):2038-45.
2003: J Panicker; Indira Warrier; Ron L Thomas; Jeanne M Lusher
The overall effectiveness of prophylaxis in severe haemophilia.
Haemophilia : the official journal of the World Federation of Hemophilia 2003;9(3):272-8.
2003: Jeanne M Lusher; C A Lee; Craig M Kessler; C L Bedrosian
The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe haemophilia A.
Haemophilia : the official journal of the World Federation of Hemophilia 2003;9(1):38-49.
2003: Dorothy Barnard; Michael Woloski; David Feeny; Patricia McCusker; John Wu; Michele David; James Bussel; Jeanne M Lusher; Cindy D Wakefield; Susan Henriques; Victor Blanchette
Development of disease-specific health-related quality-of-life instruments for children with immune thrombocytopenic purpura and their parents.
Journal of pediatric hematology/oncology 2003;25(1):56-62.
2002: Jeanne M Lusher
Highlights from the XXV International Congress of the World Federation of Hemophilia. May 19-24, 2002, Seville, Spain.
MedGenMed : Medscape general medicine 2002;4(3):14.
2002: Jeanne M Lusher
First and second generation recombinant factor VIII concentrates in previously untreated patients: recovery, safety, efficacy, and inhibitor development.
Seminars in thrombosis and hemostasis 2002;28(3):273-6.
2001: Gilbert C White; F Rosendaal; Louis M Aledort; Jeanne M Lusher; Chantal Rothschild; Jørgen Ingerslev
Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis.
Thrombosis and haemostasis 2001;85(3):560.
2001: Roshni Kulkarni; Jeanne M Lusher
Perinatal management of newborns with haemophilia.
British journal of haematology 2001;112(2):264-74.
2000: Bruce M Ewenstein; W Keith Hoots; Jeanne M Lusher; Donna DiMichele; Gilbert C White; B Adelman; K Nadeau
Inhibition of CD40 ligand (CD154) in the treatment of factor VIII inhibitors.
Haematologica 2000;85(10 Suppl):35-9.
2000: Jeanne M Lusher
Hemophilia treatment. Factor VIII inhibitors with recombinant products: prospective clinical trials.
Haematologica 2000;85(10 Suppl):2-5; discussion 5-6.
2000: Jeanne M Lusher
Inhibitors in young boys with haemophilia.
Baillière's best practice & research. Clinical haematology 2000;13(3):457-68.
2000: A Unuvar; Indira Warrier; Jeanne M Lusher
Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors.
Haemophilia : the official journal of the World Federation of Hemophilia 2000;6(3):150-7.
2000: Jeanne M Lusher
Recombinant clotting factors: a review of current clinical status.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 2000;13(4):289-98.
2000: Jeanne M Lusher
Acute hemarthroses: the benefits of early versus late treatment with recombinant activated factor VII.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2000;11 Suppl 1():S45-9.
2000: Margaret V Ragni; Jeanne M Lusher; Marion A Koerper; M Manco-Johnson; D S Krause
Safety and immunogenicity of subcutaneous hepatitis A vaccine in children with haemophilia.
Haemophilia : the official journal of the World Federation of Hemophilia 2000;6(2):98-103.
2000: Jeanne M Lusher
Inhibitor antibodies to factor VIII and factor IX: management.
Seminars in thrombosis and hemostasis 2000;26(2):179-88.
1999: Roshni Kulkarni; Jeanne M Lusher; Rebecca C Henry; David J Kallen
Current practices regarding newborn intracranial haemorrhage and obstetrical care and mode of delivery of pregnant haemophilia carriers: a survey of obstetricians, neonatologists and haematologists in the United States, on behalf of the National Hemophilia Foundation's Medical and Scientific Advisory Council.
Haemophilia : the official journal of the World Federation of Hemophilia 1999;5(6):410-5.
1999: Jeanne M Lusher
Gene therapy for hemophilia A and B: patient selection and follow-up, requirements for a cure.
Thrombosis and haemostasis 1999;82(2):572-5.
1999: Jeanne M Lusher
Recombinant factor VIIa: a viewpoint by Jeanne M. Lusher.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 1999;12(1):78-9.
1999: Jeanne M Lusher
Systemic causes of excessive uterine bleeding.
Seminars in hematology 1999;36(3 Suppl 4):10-20.
1999: Roshni Kulkarni; Jeanne M Lusher
Intracranial and extracranial hemorrhages in newborns with hemophilia: a review of the literature.
Journal of pediatric hematology/oncology 1999;21(4):289-95.
1999: Erik C Thorland; Joni B Drost; Jeanne M Lusher; Indira Warrier; Amy D Shapiro; Marion A Koerper; Donna DiMichele; J Westman; Nigel S Key; Steve S Sommer
Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest risk.
Haemophilia : the official journal of the World Federation of Hemophilia 1999;5(2):101-5.
1999: Jeanne M Lusher
Inhibitor development in prospective clinical trials with recombinant factor VIII preparations in previously untreated patients.
Vox sanguinis 1999;77 Suppl 1():9.
1999: S Seremetis; Jeanne M Lusher; CF Abildgaard; C K Kasper; R Allred; Deborah Hurst
Human recombinant DNA-derived antihaemophilic factor (factor VIII) in the treatment of haemophilia A: conclusions of a 5-year study of home therapy. The KOGENATE Study Group.
Haemophilia : the official journal of the World Federation of Hemophilia 1999;5(1):9-16.
1998: Nigel S Key; LM Aledort; D Beardsley; Herbert Cooper; G Davignon; Bruce M Ewenstein; GS Gilchrist; Joan Cox Gill; Bertil E Glader; W Keith Hoots; CT Kisker; Jeanne M Lusher; C G Rosenfield; Amy D Shapiro; H Smith; E Taft
Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
Thrombosis and haemostasis 1998;80(6):912-8.
1998: Jeanne M Lusher; Harold R Roberts; G Davignon; J H Joist; H Smith; Amy D Shapiro; Y Laurian; C K Kasper; P M Mannucci
A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group.
Haemophilia : the official journal of the World Federation of Hemophilia 1998;4(6):790-8.
1998: Jeanne M Lusher; Carol Hillman-Wiseman; Deborah Hurst
In vivo recovery with products of very high purity--assay discrepancies.
Haemophilia : the official journal of the World Federation of Hemophilia 1998;4(4):641-5.
1998: Indira Warrier; Jeanne M Lusher
Development of anaphylactic shock in haemophilia B patients with inhibitors.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1998;9 Suppl 1():S125-8.
1998: Jeanne M Lusher
Recombinant activated factor VII for treatment of intramuscular haemorrhages: a comparison of early versus late treatment.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1998;9 Suppl 1():S111-4.
1998: Jeanne M Lusher; Jørgen Ingerslev; Harold R Roberts; U Hedner
Clinical experience with recombinant factor VIIa.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1998;9(2):119-28.
1998: Jeanne M Lusher
Clinical guidelines for treating von Willebrand disease patients who are not candidates for DDAVP--a survey of European physicians.
Haemophilia : the official journal of the World Federation of Hemophilia 1998;4 Suppl 3():11-4.
1998: Jeanne M Lusher
Early treatment with recombinant factor VIIa results in greater efficacy with less product.
European journal of haematology. Supplementum 1998;63():7-10.
1997: Jeanne M Lusher
Prophylaxis in children with hemophilia: is it the optimal treatment?
Thrombosis and haemostasis 1997;78(1):726-9.
1997: George R Buchanan; Pedro A. De Alarcon; S A Feig; GS Gilchrist; J N Lukens; C L Moertel; A R Cohen; J D Dickerman; E N Forman; Bertil E Glader; Jeanne M Lusher
Acute idiopathic thrombocytopenic purpura--management in childhood.
Blood 1997;89(4):1464-5; author reply 1466.
1997: Bruce M Ewenstein; Clifford M Takemoto; Indira Warrier; Jeanne M Lusher; Parvin Saidi; Joan Eisele; Lawrence J Ettinger; Donna DiMichele
Nephrotic syndrome as a complication of immune tolerance in hemophilia B.
Blood 1997;89(3):1115-6.
1997: Indira Warrier; Bruce M Ewenstein; Marion A Koerper; Amy D Shapiro; Nigel S Key; Donna DiMichele; R T Miller; John Pasi; Georges-Etienne Rivard; Steve S Sommer; J Katz; F Bergmann; Rolf Ljung; P Petrini; Jeanne M Lusher
Factor IX inhibitors and anaphylaxis in hemophilia B.
Journal of pediatric hematology/oncology 1997;19(1):23-7.
1996: Jeanne M Lusher
Screening and diagnosis of coagulation disorders.
American journal of obstetrics and gynecology 1996;175(3 Pt 2):778-83.
1996: D Menache; D L Aronson; F Darr; R R Montgomery; J C Gill; C M Kessler; Jeanne M Lusher; P D Phatak; Amy D Shapiro; A R Thompson; G C White
Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis. Cooperative Study Groups.
British journal of haematology 1996;94(4):740-5.
1996: Jeanne M Lusher; Sharada A Sarnaik
Hematology.
JAMA : the journal of the American Medical Association 1996;275(23):1814-5.
1996: Jeanne M Lusher
Recombinant clotting factor concentrates.
Baillière's clinical haematology 1996;9(2):291-303.
1996: Jeanne M Lusher
Recombinant factor VIIa (NovoSeven) in the treatment of internal bleeding in patients with factor VIII and IX inhibitors.
Haemostasis 1996;26 Suppl 1():124-30.
1996: Jeanne M Lusher; G Mariani
Protocols, dosages and clinical aspects of immune tolerance.
Vox sanguinis 1996;70 Suppl 1():60-5.
1996: Amy D Shapiro; M V Ragni; Jeanne M Lusher; S Culbert; Marion A Koerper; G E Bergman; M M Hannan
Safety and efficacy of monoclonal antibody purified factor IX concentrate in previously untreated patients with hemophilia B.
Thrombosis and haemostasis 1996;75(1):30-5.
1996: Jeanne M Lusher; C M Kessler; S E Bajardi; J Dickinson; L Augustyniak
The National Hemophilia Foundation provides a model of a national blood monitoring system.
Transfusion 1996;36(1):86-87.
1995: C Kessler; Jeanne M Lusher; G F Pierce; B Pierce; M A Koerper; J C Dickinson
Transmission of hepatitis C virus by monoclonal-purified viral-attenuated factor VIII concentrate.
Lancet 1995;346(8985):1297-8.
1995: Indira Warrier; Jeanne M Lusher
Congenital thrombocytopenias.
Current opinion in hematology 1995;2(5):395-401.
1995: Carol K Kasper; D L Aronson; G Davignon; P Foster; C Hillman-Wiseman; Jeanne M Lusher; M Manco-Johnson; J B Meade; R R Montgomery; F R Rickles
Comparison of six commercial plasma references for factor VIII, factor IX and von Willebrand factor. On behalf of the Subcommittee for Factor VIII and IX of the Scientific and Standardization Committee of the ISTH.
Thrombosis and haemostasis 1995;74(3):987-9.
1995: Jeffrey W Taub; Indira Warrier; C Holtkamp; D S Beardsley; Jeanne M Lusher
Characterization of autoantibodies against the platelet glycoprotein antigens IIb/IIIa in childhood idiopathic thrombocytopenia purpura.
American journal of hematology 1995;48(2):104-7.
1995: E Berntorp; V Boulyjenkov; D Brettler; M Chandy; P Jones; C Lee; Jeanne M Lusher; P Mannucci; I Peak; K Rickard
Modern treatment of haemophilia.
Bulletin of the World Health Organization 1995;73(5):691-701.
1994: Jeanne M Lusher
Transfusion therapy in congenital coagulopathies.
Hematology/oncology clinics of North America 1994;8(6):1167-80.
1994: C Hillman-Wiseman; Caroline A Vitale; Jeanne M Lusher
Factor VIII inhibitor assay using plasma F VIII versus recombinant F VIII--a comparative study.
Thrombosis research 1994;76(2):221-4.
1994: Y Laurian; Jeanne M Lusher; C M Kessler
Viral safety and clotting factor concentrates.
Thrombosis and haemostasis 1994;72(4):649.
1994: Jeanne M Lusher
Response to 1-deamino-8-D-arginine vasopressin in von Willebrand disease.
Haemostasis 1994;24(5):276-84.
1994: Jeanne M Lusher; C Kessler; Y Laurian; G Pierce
Viral contamination of blood products.
Lancet 1994;344(8919):405-6.
1994: Jeanne M Lusher
Human antibodies to recombinant factor VII in hemophiliacs.
Journal of interferon research 1994;14(4):173-4.
1994: Celeste Lindley; W T Sawyer; B G Macik; Jeanne M Lusher; J F Harrison; K Baird-Cox; K Birch; S Glazer; Harold R Roberts
Pharmacokinetics and pharmacodynamics of recombinant factor VIIa.
Clinical pharmacology and therapeutics 1994;55(6):638-48.
1994: Jeanne M Lusher
Use of prothrombin complex concentrates in management of bleeding in hemophiliacs with inhibitors--benefits and limitations.
Seminars in hematology 1994;31(2 Suppl 4):49-52.
1994: Pier M Mannucci; D B Brettler; L M Aledort; Jeanne M Lusher; C F Abildgaard; R S Schwartz; D Hurst
Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study Group.
Blood 1994;83(7):1958-62.
1994: Jeanne M Lusher
Summary of clinical experience with recombinant factor VIII products--Kogenate.
Annals of hematology 1994;68 Suppl 3():S3-6.
1993: Jeanne M Lusher
Hemophilia: continued challenges but reason for optimism on many fronts.
Transfusion 1993;33(10):791-3.
1993: S V Seremetis; L M Aledort; G E Bergman; R Bona; G Bray; D Brettler; M E Eyster; C Kessler; T S Lau; Jeanne M Lusher
Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status.
Lancet 1993;342(8873):700-3.
1993: J Addiego; C Kasper; C Abildgaard; M Hilgartner; Jeanne M Lusher; B Glader; L Aledort
Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII.
Lancet 1993;342(8869):462-4.
1993: B G Macik; Celeste Lindley; Jeanne M Lusher; W T Sawyer; A L Bloom; J F Harrison; K Baird-Cox; K Birch; S Glazer; Harold R Roberts
Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa): results of a phase I study.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1993;4(4):521-7.
1993: Carol K Kasper; Jeanne M Lusher
Recent evolution of clotting factor concentrates for hemophilia A and B. Transfusion Practices Committee.
Transfusion 1993;33(5):422-34.
1993: Jeanne M Lusher
Prediction and management of adverse events associated with the use of factor IX complex concentrates.
Seminars in hematology 1993;30(2 Suppl 1):36-40.
1993: M J Nowicki; James W Mosley; Marion A Koerper; L M Aledort; Jeanne M Lusher; M W Hilgartner
Passive antibody to hepatitis A virus in US haemophiliacs.
Lancet 1993;341(8844):562.
1993: Jeanne M Lusher; S Arkin; C F Abildgaard; R S Schwartz
Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group.
The New England journal of medicine 1993;328(7):453-9.
1993: L M Aledort; Eva A Operskalski; S L Dietrich; Marion A Koerper; G F Gjerset; Jeanne M Lusher; Eric C-Y Lian; James W Mosley
Low CD4+ counts in a study of transfusion safety. The Transfusion Safety Study Group.
The New England journal of medicine 1993;328(6):441-2.
1992: M Inwood; Jeanne M Lusher
Clinical trials of the recombinant factor VIII product, Kogenate.
Transfusion medicine reviews 1992;6(4):261-2.
1992: Jeanne M Lusher; Indira Warrier
Hemophilia A.
Hematology/oncology clinics of North America 1992;6(5):1021-33.
1992: Mary Ann Fletcher; James W Mosley; J Hassett; G F Gjerset; Joseph Kaplan; J W Parker; Elizabeth A Donegan; Jeanne M Lusher; H Lee
Effect of age on human immunodeficiency virus type 1-induced changes in lymphocyte populations among persons with congenital clotting disorders. Transfusion Safety Study Group.
Blood 1992;80(3):831-40.
1992: L M Aledort; M W Hilgartner; Malcolm Pike; G F Gjerset; Marion A Koerper; Eric C-Y Lian; Jeanne M Lusher; James W Mosley
Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study Group.
BMJ (Clinical research ed.) 1992;304(6821):212-6.
1991: Jeanne M Lusher
Perspectives on the use of factor IX complex concentrates in the treatment of bleeding in persons with acquired factor VIII inhibition.
The American journal of medicine 1991;91(5A):30S-34S.
1991: Jeanne M Lusher
Viral safety and inhibitor development associated with monoclonal antibody-purified F VIII C.
Annals of hematology 1991;63(3):138-41.
1991: Jeanne M Lusher; Eva A Operskalski; L M Aledort; S L Dietrich; G F Gjerset; M W Hilgartner; Marion A Koerper; C H Pegelow; H Lee; James W Mosley
Risk of human immunodeficiency virus type 1 infection among sexual and nonsexual household contacts of persons with congenital clotting disorders.
Pediatrics 1991;88(2):242-9.
1991: Jeanne M Lusher
Thrombogenicity associated with factor IX complex concentrates.
Seminars in hematology 1991;28(3 Suppl 6):3-5.
1991: Jeanne M Lusher; Indira Warrier
Hemophilia.
Pediatrics in review / American Academy of Pediatrics 1991;12(9):275-81.
1991: M L Lee; Jeanne M Lusher
The problem of therapeutic equivalence with paired qualitative data: an example from a clinical trial using haemophiliacs with an inhibitor to factor VIII.
Statistics in medicine 1991;10(3):433-41.
1990: Jeanne M Lusher
Lack of inhibitor to monoclonal-antibody purified factor VIII concentrate.
Lancet 1990;336(8725):1249-50.
1990: Pier M Mannucci; K Schimpf; D B Brettler; N Ciavarella; Massimo Colombo; F Haschke; K Lechner; Jeanne M Lusher; G Weissbach
Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study Group.
Annals of internal medicine 1990;113(1):27-32.
1990: Kenneth J Smith; Jeanne M Lusher; A R Cohen; P Salzman
Initial clinical experience with a new pasteurized monoclonal antibody purified factor VIIIC.
Seminars in hematology 1990;27(2 Suppl 2):25-9.
1990: Jeanne M Lusher; P M Salzman
Viral safety and inhibitor development associated with factor VIIIC ultra-purified from plasma in hemophiliacs previously unexposed to factor VIIIC concentrates. The Monoclate Study Group.
Seminars in hematology 1990;27(2 Suppl 2):1-7.
1990: Indira Warrier; Jeanne M Lusher
Retrovir therapy in hemophilic children with symptomatic human immunodeficiency virus infection: efficacy and toxicity.
The American journal of pediatric hematology/oncology 1990;12(2):160-3.
1990: S L Dietrich; James W Mosley; Jeanne M Lusher; M W Hilgartner; Eva A Operskalski; L Habel; L M Aledort; G F Gjerset; Marion A Koerper; B H Lewis
Transmission of human immunodeficiency virus type 1 by dry-heated clotting factor concentrates. Transfusion Safety Study Group.
Vox sanguinis 1990;59(3):129-35.
1990: Jeanne M Lusher
Strategies to promote hemostasis in patients with F VIII inhibitors.
Progress in clinical and biological research 1990;324():39-46.
1989: P M Mannucci; Jeanne M Lusher
Desmopressin and thrombosis.
Lancet 1989;2(8664):675-6.
1989: Gobinda Sarkar; Mark I Evans; S Kogan; Jeanne M Lusher; Steve S Sommer
Accurate prenatal diagnosis with novel polymerase chain reaction primers in a family with sporadic hemophilia A.
Obstetrics and gynecology 1989;74(3 Pt 1):414-7.
1989: G F Pierce; Jeanne M Lusher; A P Brownstein; J C Goldsmith; C M Kessler
The use of purified clotting factor concentrates in hemophilia. Influence of viral safety, cost, and supply on therapy.
JAMA : the journal of the American Medical Association 1989;261(23):3434-8.
1989: D B Brettler; A D Forsberg; P H Levine; L M Aledort; M W Hilgartner; C K Kasper; Jeanne M Lusher; C McMillan; Harold R Roberts
The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience.
Archives of internal medicine 1989;149(6):1381-5.
1988: Joseph Kaplan; I Sarnaik; Jeanne M Lusher
Increase in Leu 2+ Leu 7+ lymphocytes in HIV 1-seropositive patients with hemophilia repeatedly treated with clotting factor concentrates.
Clinical immunology and immunopathology 1988;46(3):337-41.
1987: Jeanne M Lusher; Indira Warrier
Use of intravenous gamma globulin in children and adolescents with idiopathic thrombocytopenic purpura and other immune thrombocytopenias.
The American journal of medicine 1987;83(4A):10-6.
1987: Jeanne M Lusher
Management of patients with factor VIII inhibitors.
Transfusion medicine reviews 1987;1(2):123-30.
1987: Jeanne M Lusher
Factor VIII inhibitors. Etiology, characterization, natural history, and management.
Annals of the New York Academy of Sciences 1987;509():89-102.
1986: Indira Warrier; Jeanne M Lusher
Intravenous gammaglobulin (Gaminume) for treatment of chronic idiopathic thrombocytopenic purpura (ITP): a two-year follow-up.
American journal of hematology 1986;23(4):323-8.
1986: Sharada A Sarnaik; J Schornack; Jeanne M Lusher
The incidence of development of irregular red cell antibodies in patients with sickle cell anemia.
Transfusion 1986;26(3):249-52.
1986: Indira Warrier; C A Brennan; Jeanne M Lusher
Familial warfarin resistance in a black child.
The American journal of pediatric hematology/oncology 1986;8(4):346-7.
1985: Jeanne M Lusher
Factor VIII concentrates: matching what you see with what you get.
JAMA : the journal of the American Medical Association 1985;254(6):802-3.
1984: Joseph Kaplan; Sharada A Sarnaik; J Gitlin; Jeanne M Lusher
Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions.
Blood 1984;64(1):308-10.
1984: Indira Warrier; Jeanne M Lusher
Intravenous gamma globulin treatment for chronic idiopathic thrombocytopenic purpura in children.
The American journal of medicine 1984;76(3A):193-8.
1984: Jeanne M Lusher
Myocardial necrosis after therapy with prothrombin-complex concentrate.
The New England journal of medicine 1984;310(7):464.
1984: Jeanne M Lusher; A Emami; Yaddanapudi Ravindranath; A I Warrier
Idiopathic thrombocytopenic purpura in children. The case for management without corticosteroids.
The American journal of pediatric hematology/oncology 1984;6(2):149-57.
1984: Jeanne M Lusher
The role of prothrombin complex concentrates in the treatment of hemophiliacs with factor VIII inhibitors.
Scandinavian journal of haematology. Supplementum 1984;40():195-202.
1984: Jeanne M Lusher; Frederick A Ofosu; J R Edson; J H Joist; S I Chavin; A E Weiss; C R Hillman
North American study of factor VIII concentrate potency.
Scandinavian journal of haematology. Supplementum 1984;40():149-60.
1984: Jeanne M Lusher; M E Eyster; M W Hilgartner; C K Kasper; P M Mannucci; I M Nilsson; J A Penner; Harold R Roberts
Panel discussion on the treatment of patients with factor VIII inhibitors.
Progress in clinical and biological research 1984;150():323-35.
1984: Jeanne M Lusher
Controlled clinical trials with prothrombin complex concentrates.
Progress in clinical and biological research 1984;150():277-90.
1984: Jeanne M Lusher
Assessment of response to treatment and design of clinical trials.
Progress in clinical and biological research 1984;150():167-79.
1983: Jeanne M Lusher; P M Blatt; J A Penner; L M Aledort; P H Levine; G C White; A I Warrier; D A Whitehurst
Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIII.
Blood 1983;62(5):1135-8.
1983: M I Barnhart; S Chen; Jeanne M Lusher
DDAVP: does the drug have a direct effect on the vessel wall?
Thrombosis research 1983;31(2):239-53.
1983: A I Warrier; Jeanne M Lusher
DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease.
The Journal of pediatrics 1983;102(2):228-33.
1983: A Emami; Yaddanapudi Ravindranath; S Inoue; Joseph Kaplan; Jeanne M Lusher
Phenotypic change of acute monocytic leukemia to acute lymphoblastic leukemia on therapy.
The American journal of pediatric hematology/oncology 1983;5(4):341-3.
1982: Sharada A Sarnaik; Jeanne M Lusher
Neurological complications of sickle cell anemia.
The American journal of pediatric hematology/oncology 1982;4(4):386-94.
1981: M W Fullerton; A I Philippart; Sharada A Sarnaik; Jeanne M Lusher
Preoperative exchange transfusion in sickle cell anemia.
Journal of pediatric surgery 1981;16(3):297-300.
1981: R P Warrier; Yaddanapudi Ravindranath; A Emami; Jeanne M Lusher
Exchange transfusion for hyperleukocytosis, anemia, and metabolic abnormalities in leukemia.
The Journal of pediatrics 1981;98(2):338-9.
1981: Yaddanapudi Ravindranath; D T Soorya; G E Schultz; Jeanne M Lusher
Long-term survivors of acute lymphoblastic leukemia--risk of relapse after cessation of therapy.
Medical and pediatric oncology 1981;9(3):209-18.
1981: M I Barnhart; R M Wilkins; Jeanne M Lusher
Platelet-vessel-wall interactions: experiences with von Willebrand platelets.
Annals of the New York Academy of Sciences 1981;370():154-78.
1980: Jeanne M Lusher; S S Shapiro; J E Palascak; A V Rao; P H Levine; P M Blatt
Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial.
The New England journal of medicine 1980;303(8):421-5.
1980: H V Kosmidis; Jeanne M Lusher; Thomas C Shope; Yaddanapudi Ravindranath; AS Dajani
Infections in leukemic children: a prospective analysis.
The Journal of pediatrics 1980;96(5):814-9.
1980: S Inoue; Yaddanapudi Ravindranath; Jeanne M Lusher; T Ito
Absence of inhibitory cells from patients with aplastic anemia or transient erythroblastopenia of childhood on the in vitro growth of erythroid colonies.
Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society 1980;43(1):76-83.
1980: S Inoue; Yaddanapudi Ravindranath; Jeanne M Lusher; T Ito
Hematological parameters and marrow in vitro colony forming cells in acute lymphoblastic leukemia after cessation of treatment.
Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society 1980;43(1):61-70.
1980: M I Barnhart; T H Kim; B L Evatt; A H Ragab; V K Lui; J Herman; Jeanne M Lusher
Essential thrombocythemia in a child: platelet ultrastructure and function.
American journal of hematology 1980;8(1):87-107.
1980: Jeanne M Lusher; S S Shapiro; J E Palascak; A V Rao; P H Levine; P M Blatt
Prothrombin complex concentrates in hemophiliacs with inhibitors--a multicenter therapeutic trial.
Transactions of the Association of American Physicians 1980;93():175-81.
1979: Sharada A Sarnaik; D Soorya; J Kim; Yaddanapudi Ravindranath; Jeanne M Lusher
Periodic transfusions for sickle cell anemia and CNS infarction.
American journal of diseases of children (1960) 1979;133(12):1254-7.
1979: P Bhanot; A J Brough; Yaddanapudi Ravindranath; Jeanne M Lusher
Primary malignant lymphoma cutis in an infant: case report and review of literature.
Pediatrics 1979;64(4):478-82.
1979: T B Haddy; Jeanne M Lusher; S Hendricks; B K Trosko
Erythropoiesis in sickle cell anaemia during acute infection and crisis.
Scandinavian journal of haematology 1979;22(4):289-95.
1979: M I Barnhart; Jeanne M Lusher
Structural physiology of the human spleen.
The American journal of pediatric hematology/oncology 1979;1(4):311-30.
1978: Jeanne M Lusher; C W McMillan
Severe factor VIII and factor IX deficiency in females.
The American journal of medicine 1978;65(4):637-48.
1978: M Alebouyeh; Jeanne M Lusher; M R Ameri; R K Evans; A Robinson
The effect of 5-hydroxytryptamine and epinephrine on newborn platelets.
European journal of pediatrics 1978;128(3):163-8.
1978: Jeanne M Lusher; Yaddanapudi Ravindranath
Acute lymphoid leukemia.
Pediatric annals 1978;7(7):466-82.
1978: Yaddanapudi Ravindranath; S Inoue; B Considine; Jeanne M Lusher; W W Zuelzer
New leukemia in the course of therapy of acute lymphoblastic leukemia.
American journal of hematology 1978;5(3):211-23.
1977: W W Zuelzer; Jeanne M Lusher
Childhood idiopathic thrombocytopenic purpura.
American journal of diseases of children (1960) 1977;131(3):360-2.
1977: B Considine; J J Cook; W W Zuelzer; Yaddanapudi Ravindranath; Jeanne M Lusher
Repetitive low-dose radiation therapy for acute stem-cell leukemia.
International journal of radiation oncology, biology, physics 1977;2(3-4):257-60.
1977: Jeanne M Lusher; M I Barnhart
Congenital disorders affecting platelets.
Seminars in thrombosis and hemostasis 1977;4(2):123-86.
1977: Jeanne M Lusher; R Iyer
Idiopathic thrombocytopenic purpura in children.
Seminars in thrombosis and hemostasis 1977;3(3):175-99.
1976: M I Barnhart; Jeanne M Lusher
The human spleen as revealed by scanning electron microscopy.
American journal of hematology 1976;1(2):243-64.
1976: W W Zeulzer; Yaddanapudi Ravindranath; Jeanne M Lusher; Sharada A Sarnaik; B Considine
IMFRA (intermittent intrathecal methotrexate and fractional radiation) plus chemotherapy in childhood leukemia.
American journal of hematology 1976;1(2):191-9.
1976: Jeanne M Lusher; H Haghighat; A S Khalifa
A prophylactic transfusion program for children with sickle cell anemia complicated by CNS infarction.
American journal of hematology 1976;1(2):265-73.
1976: M I Barnhart; C A Baechler; Jeanne M Lusher
Arteriovenous shunts in the human spleen.
American journal of hematology 1976;1(1):105-14.
1976: A S Khalifa; Jeanne M Lusher; J Cejka; W W Zuelzer
Immunoglobulins in idiopathic thrombocytopenic purpura in childhood.
Acta haematologica 1976;56(4):205-11.
1976: Jeanne M Lusher; A K Brown
Festschrift in homor of Wolf W. Zuelzer, M.D.
American journal of hematology 1976;1(2):140-1.
1975: Jeanne M Lusher
Bone changes in sickle cell disease.
Paleopathology newsletter 1975;(10):9-11.
1975: E S Hafez; M I Barnhart; H Ludwig; Jeanne M Lusher; I Joelsson; J L Daniel; A I Sherman; J A Jordan; H Wolf; W C Stewart; F C Chretien
Scanning electron microscopy of human reproductive physiology.
Acta obstetricia et gynecologica Scandinavica. Supplement 1975;40():1-61.
1974: Jeanne M Lusher; Yaddanapudi Ravindranath; E Arciniegas; E Green
Open heart surgery in a hemophiliac patient. Hematologic management.
American journal of diseases of children (1960) 1974;127(5):708-11.
1974: J Cejka; R O Bollinger; H R Schuit; Jeanne M Lusher; C H Chang; W W Zuelzer
Macroglobulinemia in a child with acute leukemia.
Blood 1974;43(2):191-9.
1972: R M Nalbandian; B M Nichols; F R Camp; N F Conte; Jeanne M Lusher; R L Henry
The detection of sickle cell hemoglobin in large human populations by an automated technique.
Military medicine 1972;137(7):261-3.
1972: K Kithier; Jeanne M Lusher; J Brought; M D Poulik
Effect of therapy on the serum level of alpha-1 fetoprotein in embryonal cell carcinoma.
The Journal of pediatrics 1972;81(1):71-5.
1972: Jeanne M Lusher; M I Barnhart
Evaluation of oral urea in the management of sickle cell anemia.
Advances in experimental medicine and biology 1972;28():303-21.
1971: R M Nalbandian; N L Henry; Jeanne M Lusher; F R Camp; N F Conte
Sickledex test for hemoglobin S. A critique.
JAMA : the journal of the American Medical Association 1971;218(11):1679-80.
1971: R M Nalbandian; B M Nichols; F R Camp; Jeanne M Lusher; N F Conte; R L Henry; P L Wolf
Automated dithionite test for rapid, inexpensive detection of hemoglobin S and non-S sickling hemoglobinopathies.
Clinical chemistry 1971;17(10):1033-7.
1971: R M Nalbandian; B M Nichols; F R Camp; Jeanne M Lusher; N F Conte; R L Henry; P L Wolf
Dithionite tube test--a rapid, inexpensive technique for the detection of hemoglobin S and non-S sickling hemoglobin.
Clinical chemistry 1971;17(10):1028-32.
1971: R M Nalbandian; J W Anderson; Jeanne M Lusher; A Agustsson; R L Henry
Oral urea and the prophylactic treatment of sickle cell disease--a preliminary report.
The American journal of the medical sciences 1971;261(6):325-34.
1971: R M Nalbandian; G Shultz; Jeanne M Lusher; J W Anderson; R L Henry
Sickle cell crisis terminated by intravenous urea in sugar solutions--a preliminary report.
The American journal of the medical sciences 1971;261(6):309-24.
1969: Jeanne M Lusher; W W Zuelzer; R K Evans
Hemophilia A in chromosomal female subjects.
The Journal of pediatrics 1969;74(2):265-71.
1968: Jeanne M Lusher; J Schneider; I Mizukami; R K Evans
The May-Hegglin anomaly: platelet function, ultrastructure and chromosome studies.
Blood 1968;32(6):950-61.
1968: Jeanne M Lusher; F Bachmann; A M Robson; L Kahn
The hematological aspects of a case of systemic lupus erythematosus.
Clinical pediatrics 1968;7(4):203-15.
1968: Jeanne M Lusher; J Shuster; R K Evans; M D Poulik
Antibody nature of an AHG (factor 8) inhibitor.
The Journal of pediatrics 1968;72(3):325-31.
1968: D J Fernbach; T B Haddy; THOMAS HOLCOMB; Jeanne M Lusher; W W Sutow; T J Vietti
Uracil mustard (NSC-34462) therapy for children with metastatic neuroblastoma.
Cancer chemotherapy reports. Part 1 1968;52(2):287-91.
1966: Jeanne M Lusher; W W Zuelzer; P J Parsons
Anti-s hemolytic disease: a case report.
Transfusion 1966;6(6):590-1.
1966: Jeanne M Lusher; W W Zuelzer
Idiopathic thrombocytopenic purpura in childhood.
The Journal of pediatrics 1966;68(6):971-9.
1964: M D COPPER; Jeanne M Lusher
IMMUNOLOGIC TOLERANCE OF ABO INCOMPATIBLE ERYTHROCYTES IN HUMAN NEONATES.
The Journal of pediatrics 1964;65():831-8.
1964: T J VIETTI; D H BERRY; D J FERNBACH; Jeanne M Lusher; W W SUTOW
URACIL MUSTARY THERAPY IN METASTATIC WILMS'S TUMOR.
American journal of diseases of children (1960) 1964;108():530-2.
1964: Jeanne M Lusher; S D FARBER
ANOTHER CASE OF MALIGNANT HYPERLIPEMIA IN INFANCY?
American journal of diseases of children (1960) 1964;108():211.
1964: Jeanne M Lusher
CHLOROMA AS A PRESENTING FEATURE OF ACUTE LEUKEMIA. A REPORT OF TWO CASES IN CHILDREN.
American journal of diseases of children (1960) 1964;108():62-6.